Lipoprotein lipase activity in patients with combined hyperlipidaemia.
The aetiology of familial combined hyperlipidaemia remains obscure, with both genetic and environmental factors contributing to the phenotype, which is frequently associated with premature coronary heart disease. We have studied lipoprotein lipase (LPL) activity and hepatic lipase (HL) activity in patients with coronary heart disease to determine whether variation in lipase activities contributes to this phenotype. Forty-one patients (mean age 50 years; 30 male) were selected on the basis of cholesterol levels above 6.5 mmol/l and triglyceride levels above 2.2 mmol/l, with apoprotein B values over the 90th percentile. There was a family history of premature coronary heart disease in 78% and a personal history in 64%, at mean age 44, the patient group therefore predominantly corresponded to the common definition of familial combined hyperlipidaemia, appropriate in the absence of molecular markers. None of the patients was diabetic; hypertension and smoking were not over represented. Blood samples were taken following intravenous administration of heparin (100 IU/kg body wt), and LPL and HL activities were measured. Mean post-heparin LPL was significantly lower in patients than controls 10 min after heparin administration (2.98 +/- 1.04 and 3.86 +/- 0.93 mumol ml-1 h-1, respectively, P = 0.001), and 37% patients had values below the 10th percentile of controls. Both male and female patients had significantly higher HL activities than their respective controls at 5, 10, 20 and 30 minutes post-heparin. As expected, both female patients and controls had lower HL activities than males, although this sex difference did not reach statistical significance in the patient group.(ABSTRACT TRUNCATED AT 250 WORDS)
Seed
M
M
Department of Medicine, Charing Cross and Westminster Medical School, London, UK.
Mailly
F
F
Vallance
D
D
Doherty
E
E
Winder
A
A
Talmud
P
P
Humphries
S E
SE
D000328:Adult; D000368:Aged; D002675:Child, Preschool; D003327:Coronary Disease / Q000150:complications* / Q000235:genetics; D005260:Female; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000150:complications / Q000201:enzymology*; D008049:Lipase / Q000097:blood; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008099:Liver / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D015995:Prevalence
D008049:Lipase; D008071:Lipoprotein Lipase